A commonly used arthritis drug is to be tested with nursing home residents who have Covid, after it was observed that those taking it for their joint pain were less likely to end up in hospital with the virus.
Older people in nursing homes, who often have some degree of dementia, tend to feel unwell in the hospital, where they become more confused and can get infections. The process will open up new horizons by providing the drug to people in nursing homes, where they can be supervised and monitored later by doctors and nurses.
The drug, adalimumab, has been in use for 20 years, and there are inexpensive versions available around the world. It is an anti-tumor necrosis factor (anti-TNF) drug, used to reduce inflammation in arthritis and bowel disease. In the severe stages of Covid-19, patients can suffer from a “cytokine storm”, an overreaction of the body’s immune system, which causes an inflammatory response:
60 million Indians may have contracted Covid